X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/nanopasss-intradermal-injection-platform-proven-to-sustain-covid-19-vaccine-antibodies-using-115-of-the-dose-reports-chinese-institute-of-medical-biology-301476501.html